DE2123046A1 - Neue 9beta, lOalpha Steroide - Google Patents

Neue 9beta, lOalpha Steroide

Info

Publication number
DE2123046A1
DE2123046A1 DE19712123046 DE2123046A DE2123046A1 DE 2123046 A1 DE2123046 A1 DE 2123046A1 DE 19712123046 DE19712123046 DE 19712123046 DE 2123046 A DE2123046 A DE 2123046A DE 2123046 A1 DE2123046 A1 DE 2123046A1
Authority
DE
Germany
Prior art keywords
general formula
solution
compound
formula
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712123046
Other languages
German (de)
English (en)
Inventor
Andor Dr Basel Labler Ludwig Dr Allschwil Meier Werner Dr Bottmingen Muller Peter Dr Ariesheim Fürst, (Schweiz), Saucy, Gabriel, Dr , Essex Falls, NJ (V St A ), Scott, John William, Dr , Widner, Erich, Dr , Ariesheim (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH749870A external-priority patent/CH565729A5/xx
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2123046A1 publication Critical patent/DE2123046A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712123046 1970-05-21 1971-05-10 Neue 9beta, lOalpha Steroide Pending DE2123046A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3956070A 1970-05-21 1970-05-21
CH749870A CH565729A5 (enExample) 1970-05-21 1970-05-21

Publications (1)

Publication Number Publication Date
DE2123046A1 true DE2123046A1 (de) 1972-01-27

Family

ID=25701459

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712123046 Pending DE2123046A1 (de) 1970-05-21 1971-05-10 Neue 9beta, lOalpha Steroide

Country Status (5)

Country Link
BE (1) BE767348A (enExample)
DE (1) DE2123046A1 (enExample)
FR (1) FR2100671B1 (enExample)
GB (2) GB1336896A (enExample)
NL (1) NL7105885A (enExample)

Also Published As

Publication number Publication date
GB1336895A (en) 1973-11-14
BE767348A (fr) 1971-11-19
FR2100671B1 (enExample) 1974-08-30
NL7105885A (enExample) 1971-11-23
GB1336896A (en) 1973-11-14
FR2100671A1 (enExample) 1972-03-24

Similar Documents

Publication Publication Date Title
DE2660851C2 (de) Derivate von Polyprenylalkoholen und diese enthaltende pharmazeutische Zusammensetzung
DE2451932A1 (de) 1-hydroxy-und 1-alkanoyloxy-3-alkyl-6, 6a,7,8,10,10a-hexahydro-9h-dibenzo eckige klammer auf b,d eckige klammer zu pyran-9one und verfahren zu ihrer herstellung
DE2717990C2 (enExample)
DE1958601A1 (de) Verfahren zur Herstellung von Steroiden
DE1227447B (de) Verfahren zur Herstellung von Phenylisopropylaminen
DE1909406C3 (de) Tricyclische Verbindungen
DE2123046A1 (de) Neue 9beta, lOalpha Steroide
DE1793693C3 (enExample)
DE1172670B (de) Verfahren zur Herstellung von 3-substituierten D-Homo-18-nor-androst-13(17a)-en-17-on-derivaten
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE3520104A1 (de) Naphthoxazine, ihre herstellung und verwendung
DE936091C (de) Verfahren zur Herstellung von 3-(p-oxysubstituierten Phenyl)-cyclohexan- bzw. -cyclohexencarbonsaeuren und deren Estern
DE2729634A1 (de) Verfahren zur herstellung von 1alpha-hydroxy-cholesterinderivaten
DE1618310C3 (enExample)
DE2731459A1 (de) Cyclohexan-analoge vom prostaglandin-typ, verfahren zu deren herstellung und diese enthaltende zusammensetzungen
DE1966921C3 (de) 17 alpha-propadienylsubstituierte 3-Ketosteroide und Verfahren zu deren Herstellung
DE2424523A1 (de) Neue 1,2,3,4-tetrahydrocarbazol-derivate und verfahren zu deren herstellung
DE2212589A1 (de) Verfahren zur Herstellung von Triensteroid-Derivaten
DE2747987A1 (de) 4-amino-benzo(b)bicyclo eckige klammer auf 3,3,1 eckige klammer zu -nonen-derivate und verfahren zu ihrer herstellung und arzneimittel, enthaltend diese verbindungen
DE900938C (de) Verfahren zur Herstellung von 1-(o-Oxyphenyl)-1-oxy-2-aralkylamino-propanen
EP0034114A1 (de) 3-Desoxy-delta-15-Steroide, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
AT218521B (de) Verfahren zur Herstellung von neuen Derivaten des Piperidins und Tetrahydropyridins
DE2056512C3 (enExample)
DE1493963C (de) Substituierte Flavandenvate sowie Verfahren zu ihrer Herstellung
DE1097986B (de) Verfahren zur Herstellung von 6ª‡-Methyl-17ª‡-oxyprogesteron sowie von dessen Estern

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination